Townsend & Associates’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.7M | Sell |
184,176
-30,623
| -14% | -$2.45M | 1.46% | 26 |
|
|
2025
Q1 | $14.9M | Buy |
214,799
+34,048
| +19% | +$2.36M | 1.55% | 28 |
|
|
2024
Q4 | $12.6M | Buy |
180,751
+5,773
| +3% | +$404K | 1.3% | 35 |
|
|
2024
Q3 | $12.4M | Buy |
174,978
+8,441
| +5% | +$596K | 1.27% | 35 |
|
|
2024
Q2 | $10.4M | Buy |
166,537
+3,960
| +2% | +$247K | 1.15% | 38 |
|
|
2024
Q1 | $14.3M | Buy |
162,577
+1,867
| +1% | +$164K | 1.66% | 29 |
|
|
2023
Q4 | $11.7M | Buy |
160,710
+84,306
| +110% | +$6.12M | 1.46% | 33 |
|
|
2023
Q3 | $4.71M | Buy |
76,404
+34,123
| +81% | +$2.11M | 1% | 35 |
|
|
2023
Q2 | $3.88M | Buy |
42,281
+18,623
| +79% | +$1.71M | 1% | 36 |
|
|
2023
Q1 | $2.08M | Buy |
23,658
+15,287
| +183% | +$1.34M | 0.84% | 45 |
|
|
2022
Q4 | $650K | Buy |
+8,371
| New | +$650K | 0.32% | 67 |
|